Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Foreword – European Ophthalmic Review, 2011;5(2):96

Anat Loewenstein
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Published Online: Jan 24th 2012
Select a Section…
1

Article

It is with great enthusiasm that I recommend to the readers this interesting issue of the European Ophthalmic Review for its wide-ranging coverage of hot topics and innovations in all subspecialities of ophthalmology. Each review stands for itself in being comprehensive and fascinating; nonetheless, the common denominators of the included papers are remarkable.


It is with great enthusiasm that I recommend to the readers this interesting issue of the European Ophthalmic Review for its wide-ranging coverage of hot topics and innovations in all subspecialities of ophthalmology. Each review stands for itself in being comprehensive and fascinating; nonetheless, the common denominators of the included papers are remarkable.
First, our endeavour to use safer methods of treatment and minimise incision size, thus intruding as little as possible into the normal eye structure, is manifested in the review on the treatment of diabetic macular oedema, beautifully illustrated by Francesco Bandello.
However, the concept that presents itself loud and clear from the majority of papers in the current issue is highlighting the importance of advanced imaging techniques for the way we diagnose, treat and follow up our patients. Using the ‘IOLMaster® 500 and Integration of the Holladay 2 Formula for Intraocular Lens Calculations’ is emphasising how we can improve our surgical results by using more sophisticated methods for imaging and measurements. The paper on intraocular pressure contact lenses also calls to attention how better diagnosis of the pressure status in a continuous manner can change the way we treat our patients.
‘Macular Pigment Density Measurement in Patients with Age-related Macular Degeneration’ may prove to be an important diagnostic and prognostic tool as demonstrated by Jens Dawczynski and colleagues.
In summary, this issue provides us with new data on techniques and imaging which are very likely to transform and modulate the way we treat our patients. ■

2

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Close Popup